||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 501 active entries
3300 Duval Road
United States of America, Texas
Toll free: 888 726 6277
Phone: 512 835 8026
Fax: 512 835 4687
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Rules-Based Medicine (RBM) provides comprehensive protein biomarker products and services centered on its Multi-Analyte Profiling (MAP) technology. Its service platform (RodentMAP® and HumanMAP®) provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The testing service supports numerous GLP studies and is CLIA certified. Many of these assays are becoming available as optimized kits through our distribution partner EMD Biosciences in the Summer of 2008. The company also offers innovative and proprietary ex vivo testing systems such as TruCulture™, the first fully-closed, reproducible whole blood culture system. It is available with a MAP testing service that provides an unprecedented view of the impact of a drug compound or consumer product on an individual’s immune system without endangering a human test subject. RBM is actively developing multiplex diagnostic tests to detect the presence of complex disease and conditions in areas of unmet medical need such as neuropsychiatry, nephrology, immunology and cardiology. More information about RBM is located at www.rbmmaps.com.
Last update of this entry: June 28, 2008